Description

Jardy-Met tablets combine empagliflozin and metformin to control high blood sugar in individuals with type 2 diabetes. Empagliflozin works by increasing sugar removal through the kidneys, while metformin improves insulin utilization. This combination helps in effective glycemic control and reduces the risk of cardiovascular events. However, it is advised to avoid this medication during pregnancy, and patients should be aware that it may affect their ability to drive.